We provide investors and healthcare companies with operations in the United States as well as the United Kingdom and Europe with a multi-country regulatory and reimbursement outlook.  We are uniquely positioned to leverage experienced professionals from the US and UK/Europe into one seamless team that provides a detailed analysis of the risks and opportunities faced by transatlantic businesses. We understand the importance of being able to see the political, economic and cultural nuances that impact local market conditions and provide the granular insights that matter to our clients.

Our Transatlantic Transaction Advisory team draws on professional staff from the US, UK and Europe and is comprised of former White House, US Congress and state Medicaid officials as well as individuals with experience from the Department of Health, NHS England, Care Quality Commission, Local Authorities and European Parliament.